Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Treatment for stage I-testicular cancer should be assessed individually].
Oldenburg J, Haugnes HS, Dahl O, Karlsdottir Å, Langberg CW, Klepp O, Solberg A, Tandstad T. Oldenburg J, et al. Among authors: klepp o. Tidsskr Nor Laegeforen. 2015 Aug 25;135(15):1340-1. doi: 10.4045/tidsskr.15.0544. eCollection 2015 Aug 25. Tidsskr Nor Laegeforen. 2015. PMID: 26315230 Free article. Norwegian. No abstract available.
Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
Tandstad T, Smaaland R, Solberg A, Bremnes RM, Langberg CW, Laurell A, Stierner UK, Ståhl O, Cavallin-Ståhl EK, Klepp OH, Dahl O, Cohn-Cedermark G. Tandstad T, et al. Among authors: klepp oh. J Clin Oncol. 2011 Feb 20;29(6):719-25. doi: 10.1200/JCO.2010.30.1044. Epub 2011 Jan 4. J Clin Oncol. 2011. PMID: 21205748
Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group.
Olofsson SE, Tandstad T, Jerkeman M, Dahl O, Ståhl O, Klepp O, Bremnes RM, Cohn-Cedermark G, Langberg CW, Laurell A, Solberg A, Stierner U, Wahlqvist R, Wijkström H, Anderson H, Cavallin-Ståhl E. Olofsson SE, et al. Among authors: klepp o. J Clin Oncol. 2011 May 20;29(15):2032-9. doi: 10.1200/JCO.2010.29.1278. Epub 2011 Apr 11. J Clin Oncol. 2011. PMID: 21482994 Clinical Trial.
[Re: Different guidelines for treatment of prostate cancer].
Solberg A, Angelsen A, Berge V, Lilleby W, Iversen J, Klepp O, Brennhovd B, Johannessen D, Nygård Y, Larsen K, Stensvold A. Solberg A, et al. Among authors: klepp o. Tidsskr Nor Laegeforen. 2015 Jun 30;135(12-13):1105. doi: 10.4045/tidsskr.15.0652. eCollection 2015 Jun 30. Tidsskr Nor Laegeforen. 2015. PMID: 26130530 Free article. Norwegian. No abstract available.
Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study.
Tandstad T, Cohn-Cedermark G, Dahl O, Stierner U, Cavallin-Stahl E, Bremnes RM, Klepp O. Tandstad T, et al. Among authors: klepp o. Ann Oncol. 2010 Sep;21(9):1858-1863. doi: 10.1093/annonc/mdq026. Epub 2010 Feb 8. Ann Oncol. 2010. PMID: 20142410 Free article. Clinical Trial.
Long-term Relative Survival after Diagnosis of Testicular Germ Cell Tumor.
Kvammen Ø, Myklebust TÅ, Solberg A, Møller B, Klepp OH, Fosså SD, Tandstad T. Kvammen Ø, et al. Among authors: klepp oh. Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):773-9. doi: 10.1158/1055-9965.EPI-15-1153. Epub 2016 Feb 11. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26908435
[Brachytherapy in prostatic cancer].
Norderhaug I, Johansen TB, Dahl O, Høisaeter PA, Heikkilä R, Klepp O, Olsen DR, Kristiansen IS, Waehre H. Norderhaug I, et al. Among authors: klepp o. Tidsskr Nor Laegeforen. 2002 Nov 30;122(29):2795-8. Tidsskr Nor Laegeforen. 2002. PMID: 12523149 Review. Norwegian.
142 results